FGFR4 and neoplasm: Intracranial injection of BTL1528 GFP cells led to tumor bulk formation in 100% of cases (n = 5) (Fig. 6H + I), while none of the BTL1528 FGFR4-KD(K504M)-implanted mice (n = 5) developed detectable tumors (Fig. 6H).